SHARE-BASED COMPENSATION (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Jan. 30, 2022	Jan. 31, 2021
Share-based Compensation [Abstract]
Maximum number of shares of common stock that may be issued (in shares)	4,000,000
Expense reported in:
Expense incurred	$ 1,457	$ 1,301
Income tax benefits of share-based compensation	100	0
Share-based compensation cost capitalized	0	0
Cost of Goods Sold [Member]
Expense reported in:
Expense incurred	143	112
Selling, General and Administrative [Member]
Expense reported in:
Expense incurred	1,180	1,097
Research and Development [Member]
Expense reported in:
Expense incurred	134	92
Restricted Stock [Member]
Expense reported in:
Expense incurred	$ 1,367	$ 1,171
Restricted Stock [Abstract]
Number of shares granted in period (in shares)	535,400	541,200
Weighted-average grant-date fair value of awards (in dollars per share)	$ 19.28	$ 11.13
Shares outstanding at balance sheet date (in shares)	1,128,179	1,059,001
Estimated Expenses Not Yet Incurred [Abstract]
Compensation cost not yet recognized	$ 15,106	$ 10,564
Weighted-average amortization period for cost not yet recognized (in years)	3 years	3 years
Restricted Stock [Member] | Minimum [Member]
Expense reported in:
Award vesting period	1 year
Restricted Stock [Member] | Maximum [Member]
Expense reported in:
Award vesting period	4 years
Stock Options [Member]
Expense reported in:
Expense incurred	$ 38	$ 84
Stock options activity [Abstract]
Contractual term	10 years
Number of options granted in period (in shares)	0	0
Cash received from option exercised	$ 3,714	$ 658
Estimated Expenses Not Yet Incurred [Abstract]
Compensation cost not yet recognized	$ 71	$ 282
Weighted-average amortization period for cost not yet recognized (in years)	1 year	1 year 7 months 6 days
Outstanding and exercisable option awards [Roll Forward]
Outstanding at end of period (in shares)	769,513
Exercisable at end of period (in shares)	745,287
Weighted-Average Exercise Price [Abstract]
Outstanding at end of period (in dollars per share)	$ 9.81
Exercisable at end of period (in dollars per share)	$ 9.81
Weighted-Average Remaining Contractual Life (in years) [Abstract]
Outstanding at end of period	4 years
Exercisable at end of period	3 years 10 months 24 days
Aggregate Intrinsic Value [Abstract]
Outstanding at end of period	$ 5,797
Exercisable at end of period	$ 5,613
Stock Options [Member] | Minimum [Member]
Expense reported in:
Award vesting period	1 year
Stock Options [Member] | Maximum [Member]
Expense reported in:
Award vesting period	4 years
ESPP [Member]
Expense reported in:
Expense incurred	$ 52	$ 46